RMF, SZ, SC, AFS, OAG, DV, CVS, and SB have no relevant financial or non-financial interests to disclose.

FAK has received research support from Bayer, BMS, BSCI, AstraZeneca, angiodynamics, MSD, Leo Pharma, Actelion, Varm-X, The Netherlands Organisation for Health Research and Development, The Dutch Thrombosis Foundation, The Dutch Heart Foundation and the Horizon Europe Program, all outside this work and paid to his institution.

SVK reports research grants and advisory contracts via his institution from Bayer AG, Daiichi Sankyo, Boston Scientific, Penumbra, and Inari Medical/Stryker; and personal consulting or lecture fees from Daiichi Sankyo, Boston Scientific, Penumbra, Inari Medical/Stryker, and Novartis, all outside the submitted work.

NK received grant support from the Swiss National Science Foundation, Concept Medical, Bayer, Becton Dickenson, Boston Scientific, and Medtronic. He also received consultancy or lecturer fees from Boston Scientific and Becton Dickenson.